Paul Tudor Jones’ New Bets: Baidu and Citigroup Among the Largest

Last Friday, Paul Tudor Jones‘ Tudor Investment Corp filed its 13F Form with the U.S. Securities and Exchange Commission, disclosing its equity positions as of the end of the fourth quarter of 2013. We have found that the most popular small cap stocks among hedge funds outperformed the market by 18 percentage points even though we started measuring the returns a couple of weeks after 13Fs have been made public. It can also be productive to treat individual 13Fs as free recommendations from fund managers- not necessarily to be followed, but to be considered briefly and then researched further if they seem appealing.

Below, I will look into Tudor’s new stock positions (in which it invested more than $560 million in aggregate). This employee hedge fund sponsor manages separate client-focused portfolios and has an equity portfolio worth more than $2 billion. It’s largest stakes are placed in the ETFs, followed by services and technology stocks.

TUDOR INVESTMENT CORP

Tudor’s biggest new bet of Q4 was placed on iShares MSCI South Korea Index Fund(ETF) (NYSEARCA:EWY), an ETF that trades at the New York Archipelago Exchange. The fund started a position with 2.5 million shares, worth more than $161.6 million. However, at InsiderMonkey, we keep our focus on U.S. traded companies, over ETFs and bonds.

Among publicly traded companies, Mr. Tudor Jones seems to feel most bullish about Baidu Inc (ADR) (NASDAQ:BIDU), the large-cap Chinese-language Internet search provider. Despite the company’s industry leading margins, returns, and growth history, its valuation still looks reasonable (at 50 times the company’s earnings, versus an industry average of 44x). Probably betting on these fundamentals, and on the company’s long-term growth prospects, which double its industry’s average, Tudor acquired 195,000 shares of Baidu Inc (ADR) (NASDAQ:BIDU), currently valued at approximately $34.69 million.

The second-runner is the banking giant Citigroup Inc (NYSE:C). Over the fourth quarter, the fund started a position in the company, acquiring 418,951 shares, with a reported value of $21.8 million. Since the purchase, the stock price has been pretty much flat, but an upside may come soon. The stock price is expected to gain ground over the next few years, mainly on the back of an above average EPS growth rate of 19%-20%.

Cardinal Health Inc (NYSE:CAH) - one of the most powerful players within the pharmaceutical supply chain- comes in next among Tudor’s largest new positions. Despite the company’s razor thin margins and returns, poor growth history and above average valuation (at 65 times the company’s earnings), both hedge funds and analysts seem to be quite fond of this stock. Probably, it is its economic moat and dividend yield that make this option attractive. This might be the reason why Tudor procured 304,200 shares of the company, worth about $21.3 million.

Another interesting case is that of ManpowerGroup Inc. (NYSE:MAN), an employment services provider with a market cap of $6 billion. Once again, weak fundamentals have not stopped Tudor from acquiring this stock. A reasonable valuation, a 1.2% dividend yield and decent long-term EPS growth projections, make it an alluring option, notwithstanding. In this context, the fund bought 225,922 shares of the company.

And the last, but not the least is Chicago Bridge & Iron Company N.V. (NYSE:CBI). This integrated engineering, procurement and construction (EPC) services company any provides conceptual design, technology, engineering, procurement, fabrication, construction and commissioning services to customers in the energy, petrochemical and natural resource industries. Although it offers above average margins, and returns on average and equity, and an industry leading net income growth history, this company still trades at only 24 times its earnings, very close to the industry average. In addition, the company pays out a small dividend yield and holds long-term EPS growth projections that double its peers’ mean.  This might be the reason behind Tudor’s purchase of 225,300 shares of Chicago Bridge & Iron Company N.V. (NYSE:CBI), the reported value of the stake amounting to $18.7 million.

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Billionaire Edward Lampert’s Latest Stock Moves

Mohnish Pabrai’s Top Stock Picks

Billionaire Steve Cohen’s Top Stock Picks

 

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!